Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BARC: A Secreted Marker of Kidney Cancer

NCT00900276 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT00900276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00900276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BARC: A Secreted Marker of Kidney Cancer
Lead sponsor
Wake Forest University Health Sciences
Phase
Observational
Overall status
Completed
Start date
June 30, 2006
Completion date
April 30, 2011
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, kidney cancer, transitional cell cancer of the renal pelvis and ureter, urethral cancer